Research Article

Related GMR Articles

COX; Diabetes mellitus; MMP-9; NF-κB; Resveratrol; SIRT1

Resveratrol (RSV) has a beneficial role in the prevention of diabetes and alleviates some diabetic complications, such as cardiomyopathy. We investigated cyclooxygenase-1 (COX-1), COX-2, nuclear factor κB (NF-κB), matrix metalloproteinase-9 (MMP-9), and sirtuin 1 (SIRT1) mRNA expression levels in heart tissue after RSV treatment in streptozotocin (STZ)-induced diabetic rats. After ... more

A.S. Yar; S. Menevse; E. Alp
Endothelial cells; High glucose; Inflammation; NADPH oxidase; NF-κB; Retinoid X receptor

An inflammatory response induced by high glucose is a cause of endothelial dysfunction in diabetes and is an important contributing link to atherosclerosis. Diabetes is an independent risk factor of atherosclerosis and activation of retinoid X receptor (RXR) has been shown to exert anti-atherogenic effects. In the present study, we examined the effects of the RXR ligands 9-cis- ... more

R.B. Ning; J. Zhu; D.J. Chai; C.S. Xu; H. Xie; X.Y. Lin; J.Z. Zeng; J.X. Lin
BCA3; NF-κB; Nuclear retention; Splice

The human breast cancer-associated gene (BCA3) was first discovered in breast and prostate cancer cells lines. In vivo studies have shown that BCA3 is mainly expressed in breast tumor cells and not in normal breast and prostate tissues. To date, 3 splice variants of BCA3 have been reported: a double-absent variant lacking exon 3 and exon 5 (BCA3-1), an ... more

Y. Zhang; M.Y. Hu; C.X. Qiao; J.N. Feng; Z. Lin; B.F. Shen; Y.F. Ma; Y. Li; Y.L. Li; M. Lv
CD4; DNA methylation; EMSA; NF-κB; Porcine kidney epithelial cells

The effects of virus-like double-stranded RNA (dsRNA, PolyI:C) and DNA methyltransferase inhibitor (Aza-CdR) on CD4 gene expression were investigated in a porcine kidney cell line (PK15). We found that expression levels of TLR3 and IFNαwere significantly upregulated by PolyI:C, compared to the untreated PK15 cells, which shows that PolyI:C successfully ... more

X.S. Wang; H. Ao; L.W. Zhai; L.J. Bai; W.Y. He; C.D. Wang; Y. Yu
Chicken; Full-length cDNA; NF-κB; Nucleotide-binding oligomerization domain-containing protein -1; Receptor-interacting protein 2

Nucleotide-binding oligomerization domain-containing protein-1 (NOD1) is a cytoplasmic pattern recognition receptor (PRR) and a key member of the NOD-like receptor (NLR) family. It has been reported that NLRs recognize a variety of microbial infections to induce the host innate immune response via modulation of NF-κB signaling. However, no reports on chicken NOD1 have been ... more

Z.Y. Tao; C.H. Zhu; Z.H. Shi; C. Song; W.J. Xu; W.T. Song; J.M. Zou; A.J. Qin
Beraprost sodium; Diabetic nephropathy; Inflammatory factors; Renal function

Beraprost sodium (BPS) is a prostaglandin analogue. We investigated its effects on rats with diabetic nephropathy. There were 20 rats each in the normal control group (NC), the diabetic nephropathy group (DN), and the BPS treatment group. The rats in DN and BPS groups were given a high-fat diet combined with low-dose streptozotocin intraperitoneal injections. The rats in the BPS group ... more

J. Guan; L. Long; Y.Q. Chen; Y. Yin; L. Li; C.X. Zhang; L. Deng; L.H. Tian
Diabetic nephropathy; Fibronectin; Human mesangial cells; Monocyte chemoattractant protein-1; Mycophenolate mofetil

The effects of high glucose on the expression of monocyte chemoattractant protein-1 (MCP-1) and the main component of the extracellular matrix, fibronectin (FN), were explored in human mesangial cells (HMCs), along with the intervention effects of mycophenolate mofetil (MMF) on these indicators. Cultured HMCs were divided into five groups: 1) normal control group (5 mM glucose); 2) high ... more

F.Q. Chen; Q.Y. Wang; G.Z. Wei; X.Y. Ma; D.W. Ma; W.W. Deng; W.B. Sun
Albuminuria; Astragaloside IV; Diabetic nephropathy; Potocyte

The aims of this study were to explore the effects of Astragaloside IV on diabetic nephropathy (DN) rats. A total of 38 male Sprague-Dawley (SD) rats were divided into three groups: 10 in the normal (control) group, 14 in the DN model group, and 14 in the AS-IV group. Treatment began one week after the streptozotocin DN model was successfully established. Blood glucose and urine micro- ... more

W.S. Lu; S. Li; W.W. Guo; L.L. Chen; Y.S. Li
Diabetic nephropathy; INSR; mTOR; Polymorphisms; Type 2 diabetes mellitus

We explored the associations of INSR and mTOR, 2 key genes in the insulin signaling pathway, and the susceptibility to type 2 diabetes mellitus and diabetic nephropathy. Three single-nucleotide polymorphisms (SNPs) (rs1799817, rs1051690, and rs2059806) in INSR and 3 SNPs (rs7211818, rs7212142, and rs9674559) in mTOR were genotyped using the Sequenom ... more

A.N. Zhu; X.X. Yang; M.Y. Sun; Z.X. Zhang; M. Li
Diabetic nephropathy; Type 2 diabetes mellitus

We explored the correlation between serum YKL-40 levels and albuminuria in type 2 diabetes mellitus (T2DM) and its clinical significance. This study used a cross-sectional survey method. According to the American Diabetes Association 2007 Clinical Practice Recommendations, 738 patients with T2DM were divided into three groups: a normoalbuminuria group [albumin-to-creatinine ratio (ACR) ... more

J.Y. Han; X.Y. Ma; L.J. Yu; Y. Shao; Q.Y. Wang